Post Profile






Emails show Clinton campaign mulled over the FDA commissioner's ties to the pharma industry

On Sept. 21, 2015, Hillary Clinton tweeted a link to a story describing the 5,000% overnight hike in price of a drug called Daraprim. Shortly after, biotech company stocks took a huge hit. The excited response to the news by senior policy advisor Ann O'Leary —" FYI - We have started the war with Pharma!!" — was released after Wikileaks published Clinton campaign manager John Podesta's emails.
read more

share

Related Posts


Hillary Clinton Tweet Sends Biotech Stocks Tumbling

Politics / US Politics : Washington Wire

Biotechnology stocks took a sharp dive Monday after Hillary Clinton said she would propose a plan to counteract "price gouging" by drug makers.

Pharma CEO Who Raised Price Of AIDS Drug Allegedly Offered To Pay His Ex-Girlfriend $10,000 To Give Her Oral Sex! See The Repulsive Emails!

Pop Culture / Celebrity : Perez Hilton

By now, you might have heard of Martin Shkreli, who sparked outrage after his pharmaceutical company raised the price of the life saving drug Daraprim from $13.50 to $750 a pill overnight! After being called out by pretty much the e...

In Historic First, Massachusetts Attorney General Warns Gilead To Lower Cost Of Hep C Drug Or Face Lawsuit

Business & Finance : Zero Hedge

Late in the summer of 2015, it was one solitary tweet by Hillary Clinton which, in retaliation to Martin Shkreli's infamous "price gouging", warned biotech and pharma companies to lower prices for their drugs, that was the catalyst ...

Nets Use Drug Price Hike to Hail Hillary’s Campaign Agenda

US Politics / Conservative : NewsBusters

All three broadcast networks Tuesday morning seized on a pharmaceutical company hiking the price of a prescription drug in order to promote Hillary Clinton’s call for new government regulation of the industry. At the top of NBC’s To...

Clinton and Trump agree Prescription drugs are too expensive — and biotech is gearing up for change

News : The Raw Story

This November, the biotech industry faces an awkward decision: Donald Trump, whose policy stances have proven unpredictable; or Hillary Clinton, who can scythe drug company stock prices with a single tweet. But both candidates agree...

Comments


Copyright © 2016 Regator, LLC